One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Controversies in cardiac surgery: left main coronary disease, arterial myocardial revascularization, and prosthetic valves in dialysis
Filippo Crea
doi : 10.1093/eurheartj/ehac664
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4603–4605
Medicine of the future: a look through the keyhole
Michal Tendera
doi : 10.1093/eurheartj/ehac523
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4606–4608
New trio for interventional cardiology submissions
Judith Ozkan
doi : 10.1093/eurheartj/ehac582
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4609–4610
Thromboinflammation in cardiovascular disease: lessons learned for the management of hypertension, heart failure, and aortic valve stenosis
Philip Wenzel
doi : 10.1093/eurheartj/ehac459
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4611–4613
SGLT2 inhibitors DELIVER benefits in heart failure independently of ejection fraction and diabetes: end of the line or need for new studies?
Massimo Volpe, Daniela Pedicino
doi : 10.1093/eurheartj/ehac541
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4614–4615
The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties
Jurrien ten Berg, Bianca Rocca, Dominick J Angiolillo, Kentaro Hayashida
doi : 10.1093/eurheartj/ehac385
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4616–4634
Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure, which is used frequently in patients with symptomatic severe aortic valve stenosis.
Left main coronary disease: evolving management concepts
Paul W Armstrong, Eric R Bates, Mario Gaudino
doi : 10.1093/eurheartj/ehac542
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4635–4643
Remarkable advances in the management of coronary artery disease have enhanced our approach to left main coronary artery (LMCA) disease. The traditional role of coronary artery bypass graft surgery has been challenged by the less invasive percutaneous coronary interventional approach.
Single versus multiple arterial grafting in diabetic patients at 10 years: the Arterial Revascularization Trial
David P Taggart, Katia Audisio, Stephen Gerry, N Bryce Robinson, Mohamed Rahouma, Giovanni Jr Soletti, Gianmarco Cancelli, Umberto Benedetto, Belinda Lees, Alastair Gray, Maria Stefil, Marcus Flather, Mario Gaudino, A R T Investigators
doi : 10.1093/eurheartj/ehac199
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4644–4652
To evaluate the impact of multiple arterial grafting (MAG) vs. single arterial grafting (SAG) in a post hoc analysis of 10-year outcomes in patients with diabetes mellitus (DM) from the Arterial Revascularization Trial (ART).
The art of selection in coronary bypass grafting
Zuzana Motovska, Ibrahim Akin
doi : 10.1093/eurheartj/ehac351
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4653–4656
What is the optimal prosthetic valve in dialysis?
Kevin S Kim, Emilie Belley-Côté, Richard P Whitlock
doi : 10.1093/eurheartj/ehac396
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Pages 4657–4659
Timing of early invasive strategy in patients with non-ST-elevation acute coronary syndrome
Amer I Aladin, Cheng Zhang, Ron Waksman
doi : 10.1093/eurheartj/ehac466
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Page 4660
Timing of invasive strategy in non-ST-elevation acute coronary syndrome: risk and reward?
Thomas A Kite, Vasiliki Bountziouka, Andrew Ladwiniec
doi : 10.1093/eurheartj/ehac467
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Page 4661
Pulmonary trunk compression due to multiple aneurysms associated with a coronary-pulmonary artery fistula
Xiangfeng Gong, Jiayu Shen, Lu Liu, Zhenghua Xiao
doi : 10.1093/eurheartj/ehac441
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Page 4662
Refractory cardiogenic shock in a senile atrial fibrillation patient after left atrial appendage occlusion
Qianfeng Xiao, Xiaobo Pu, Xin Wei, Mao Chen
doi : 10.1093/eurheartj/ehac565
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Page 4663
Corrigendum to: Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
doi : 10.1093/eurheartj/ehac519
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Page 4634
Erratum to: Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial
doi : 10.1093/eurheartj/ehac534
European Heart Journal, Volume 43, Issue 44, 21 November 2022, Page 4656
